Using Topomer Comparative Molecular Field Analysis to Elucidate Activity Differences of Aminomethylenethiophene Derivatives as Lysyl Oxidase Inhibitors: Implications for Rational Design of Antimetastatic Agents for Cancer Therapy

Table 3

Newly designed molecules and predicted anti-LOX potency.

Novel compounds	Predicted pIC50
	0.48
	0.32